{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T06:13:45Z","timestamp":1770272025201,"version":"3.49.0"},"reference-count":38,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2021,1,19]],"date-time":"2021-01-19T00:00:00Z","timestamp":1611014400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,8,16]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Lymphogranuloma venereum (LGV) is a sexually transmitted infection caused by Chlamydia trachomatis (CT) serovars L1, L2, and L3 and is endemic among men who have sex with men (MSM) in Europe. We evaluated weekly oral azithromycin 1 g for 3 weeks as a treatment for LGV proctitis.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>This is an open clinical trial with convenience allocation according to treating physician preferences. Adults with clinical proctitis received a single dose of 1 g of intramuscular ceftriaxone and were subsequently allocated to receive (i) doxycycline 100 mg twice daily for 21 days (Doxycycline group) or (ii) azithromycin 1 g orally once weekly for 3 weeks (Azithromycin group). LGV cure (primary endpoint) was defined as resolution of symptoms at week 6 (clinical cure, LGV-CC), with an additional supporting negative rectal polymerase chain reaction (PCR) at week 4 (microbiological cure, LGV-MC), if available.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>One hundred and twenty-five individuals with LGV clinical proctitis were included. All were MSM, and 96% were living with human immunodeficiency virus (HIV). Eighty-two were in the Azithromycin group, and 43 were in the Doxycycline group. LGV cure on a modified intention-to-treat analysis (primary endpoint), occurred in 80 of 82 (98%) in the Azithromycin group versus 41 of 43 (95%) in the Doxycycline group (treatment difference [95% confidence interval {CI}] 2.2% [\u22123.2, 13.2]). LGV-MC occurred in 70 of 72 (97%) vs 15 of 15 (100%) in the Azithromycin group and Doxycycline group, respectively (treatment difference [95% CI] \u22122.8% [\u22129.6; 17.7]). Adverse events were similar in both treatment groups.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Our findings support extended azithromycin dosing as an alternative treatment option for symptomatic LGV proctitis and provides the rationale for future randomized trials.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/cid\/ciab044","type":"journal-article","created":{"date-parts":[[2021,1,18]],"date-time":"2021-01-18T20:24:03Z","timestamp":1611001443000},"page":"614-620","source":"Crossref","is-referenced-by-count":11,"title":["Effective Treatment of <i>Lymphogranuloma venereum<\/i> Proctitis With Azithromycin"],"prefix":"10.1093","volume":"73","author":[{"given":"Jos\u00e9 L","family":"Blanco","sequence":"first","affiliation":[{"name":"Infectious Diseases Department, ISGlobal, Hospital Clinic de Barcelona, IDIBAPS, Universitat de Barcelona, Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene","family":"Fuertes","sequence":"additional","affiliation":[{"name":"Dermatology Department, Hospital Clinic de Barcelona, Universitat de Barcelona, Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jordi","family":"Bosch","sequence":"additional","affiliation":[{"name":"Microbiology Department, ISGlobal, Hospital Clinic de Barcelona, IDIBAPS, Universitat de Barcelona, Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisa","family":"De Lazzari","sequence":"additional","affiliation":[{"name":"Infectious Diseases Department, ISGlobal, Hospital Clinic de Barcelona, IDIBAPS, Universitat de Barcelona, Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Gonzalez-Cord\u00f3n","sequence":"additional","affiliation":[{"name":"Infectious Diseases Department, ISGlobal, Hospital Clinic de Barcelona, IDIBAPS, Universitat de Barcelona, Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Vergara","sequence":"additional","affiliation":[{"name":"Microbiology Department, ISGlobal, Hospital Clinic de Barcelona, IDIBAPS, Universitat de Barcelona, Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alejandro","family":"Blanco-Arevalo","sequence":"additional","affiliation":[{"name":"Infectious Diseases Department, ISGlobal, Hospital Clinic de Barcelona, IDIBAPS, Universitat de Barcelona, Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josep","family":"Mayans","sequence":"additional","affiliation":[{"name":"Infectious Diseases Department, ISGlobal, Hospital Clinic de Barcelona, IDIBAPS, Universitat de Barcelona, Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexy","family":"Inciarte","sequence":"additional","affiliation":[{"name":"Infectious Diseases Department, ISGlobal, Hospital Clinic de Barcelona, IDIBAPS, Universitat de Barcelona, Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa","family":"Estrach","sequence":"additional","affiliation":[{"name":"Microbiology Department, ISGlobal, Hospital Clinic de Barcelona, IDIBAPS, Universitat de Barcelona, Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esteban","family":"Martinez","sequence":"additional","affiliation":[{"name":"Infectious Diseases Department, ISGlobal, Hospital Clinic de Barcelona, IDIBAPS, Universitat de Barcelona, Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ross D","family":"Cranston","sequence":"additional","affiliation":[{"name":"Infectious Diseases Department, ISGlobal, Hospital Clinic de Barcelona, IDIBAPS, Universitat de Barcelona, Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josep M","family":"Gatell","sequence":"additional","affiliation":[{"name":"University of Barcelona, and ViiV Healthcare Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Merce","family":"Alsina-Gibert","sequence":"additional","affiliation":[{"name":"Dermatology Department, Hospital Clinic de Barcelona, Universitat de Barcelona, Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2021,1,19]]},"reference":[{"key":"2021081616420154800_CIT0001","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.3201\/eid2210.160986","article-title":"Systematic review and meta-analysis of doxycycline efficacy for rectal Lymphogranuloma venereum in men who have sex with men","volume":"22","author":"Leeyaphan","year":"2016","journal-title":"Emerg Infect Dis"},{"key":"2021081616420154800_CIT0002","first-page":"277","article-title":"Chemotherapy in bubonic Lymphogranuloma venereum: a clinical and serological evaluation","volume":"16","author":"Greaves","year":"1957","journal-title":"Bull World Health Organ"},{"key":"2021081616420154800_CIT0003","doi-asserted-by":"crossref","first-page":"S865","DOI":"10.1093\/cid\/civ756","article-title":"Lymphogranuloma venereum 2015: clinical presentation, diagnosis, and treatment","volume":"61","author":"Stoner","year":"2015","journal-title":"Clin Infect Dis"},{"key":"2021081616420154800_CIT0004","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1586\/14787210.2014.901169","article-title":"Lymphogranuloma venereum among men who have sex with men. an epidemiological and clinical review","volume":"12","author":"de Vrieze","year":"2014","journal-title":"Expert Rev Anti Infect Ther"},{"key":"2021081616420154800_CIT0005","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1128\/JCM.02389-06","article-title":"Lymphogranuloma venereum in Australia: anorectal Chlamydia trachomatis serovar L2b in men who have sex with men","volume":"45","author":"Stark","year":"2007","journal-title":"J Clin Microbiol"},{"key":"2021081616420154800_CIT0006","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1136\/sextrans-2013-051404","article-title":"Risk factors for rectal Lymphogranuloma venereum in gay men: results of a multicentre case-control study in the U.K","volume":"90","author":"Macdonald","year":"2014","journal-title":"Sex Transm Infect"},{"key":"2021081616420154800_CIT0007","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1111\/jdv.15729","article-title":"2019 European guideline on the management of Lymphogranuloma venereum","volume":"33","author":"de Vries","year":"2019","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2021081616420154800_CIT0008","first-page":"1","article-title":"Sexually transmitted diseases treatment guidelines, 2015","volume":"64","author":"Workowski","year":"2015","journal-title":"MMWR Recomm Rep"},{"key":"2021081616420154800_CIT0009","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1177\/0956462413482811","article-title":"2013 UK national guideline for the management of Lymphogranuloma venereum: clinical effectiveness group of the British Association for Sexual Health and HIV (CEG\/BASHH) Guideline development group","volume":"24","author":"White","year":"2013","journal-title":"Int J STD AIDS"},{"key":"2021081616420154800_CIT0010","author":"Aliance"},{"key":"2021081616420154800_CIT0011","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1001\/jama.1948.02900060012006","article-title":"Aureomycin; a new antibiotic with virucidal properties: a preliminary report on successful treatment in 25 cases of Lymphogranuloma venereum","volume":"138","author":"Wright","year":"1948","journal-title":"J Am Med Assoc"},{"key":"2021081616420154800_CIT0012","first-page":"S147","article-title":"Treatment of Lymphogranuloma venereum.","author":"McLean","year":"2007"},{"key":"2021081616420154800_CIT0013","volume-title":"WHO guidelines for the treatment of Chlamydia trachomatis","author":"World Health Organization","year":"2016"},{"key":"2021081616420154800_CIT0014","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1258\/ijsa.2010.010329","article-title":"An audit on the management of Lymphogranuloma venereum in a sexual health clinic in London, UK","volume":"21","author":"Hill","year":"2010","journal-title":"Int J STD AIDS"},{"key":"2021081616420154800_CIT0015","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/OLQ.0000000000000578","article-title":"Treatment outcomes for rectal Lymphogranuloma venereum in men who have sex with men using doxycycline, azithromycin, or both: a review of clinical cases","volume":"44","author":"Leeyaphan","year":"2017","journal-title":"Sex Transm Dis"},{"key":"2021081616420154800_CIT0016","first-page":"209","article-title":"Lymphogranuloma venereum in Zurich, Switzerland: Chlamydia trachomatis serovar L2 proctitis among men who have sex with men","volume":"140","author":"Kamarashev","year":"2010","journal-title":"Swiss Med Wkly"},{"key":"2021081616420154800_CIT0017","doi-asserted-by":"crossref","first-page":"S759","DOI":"10.1093\/cid\/civ771","article-title":"Centers for Disease Control and Prevention sexually transmitted diseases treatment guidelines","volume":"61","author":"Workowski","year":"2015","journal-title":"Clin Infect Dis"},{"key":"2021081616420154800_CIT0018","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1002\/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I","article-title":"Interval estimation for the difference between independent proportions: comparison of eleven methods","volume":"17","author":"Newcombe","year":"1998","journal-title":"Stat Med"},{"key":"2021081616420154800_CIT0019","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1136\/sti.79.6.453","article-title":"Unusual presentation of early Lymphogranuloma venereum in an HIV-1 infected patient: effective treatment with 1 g azithromycin","volume":"79","author":"Nieuwenhuis","year":"2003","journal-title":"Sex Transm Infect"},{"key":"2021081616420154800_CIT0020","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1086\/648734","article-title":"Repeated Chlamydia trachomatis genital infections in adolescent women","volume":"201","author":"Batteiger","year":"2010","journal-title":"J Infect Dis"},{"key":"2021081616420154800_CIT0021","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1136\/sti.2009.042093","article-title":"Doxycycline failure in Lymphogranuloma venereum","volume":"86","author":"M\u00e9cha\u00ef","year":"2010","journal-title":"Sex Transm Infect"},{"key":"2021081616420154800_CIT0022","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1177\/0956462413501158","article-title":"Bubonic Lymphogranuloma venereum with multidrug treatment failure","volume":"25","author":"Vall-Mayans","year":"2014","journal-title":"Int J STD AIDS"},{"key":"2021081616420154800_CIT0023","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1258\/ijsa.2009.009134","article-title":"Lymphogranuloma venereum serovar L2b in Portugal","volume":"21","author":"Castro","year":"2010","journal-title":"Int J STD AIDS"},{"key":"2021081616420154800_CIT0024","first-page":"75","article-title":"Three weeks of doxycycline is an effective treatment for rectal Lymphogranuloma venereum","volume":"11","author":"Pallawela","year":"2010","journal-title":"HIV Medicine"},{"key":"2021081616420154800_CIT0025","doi-asserted-by":"crossref","first-page":"A139","DOI":"10.1136\/sextrans-2011-050108.96","article-title":"P1-S2.39: characteristics of Lymphogranuloma venereum (LGV) infection among homosexual men in Melbourne","volume":"87","author":"Bissessor","year":"2011","journal-title":"Sex Transm Infect"},{"key":"2021081616420154800_CIT0026","first-page":"772","article-title":"Audit of the clinical management of Lymphogranuloma venereum in three inner-city genitourinary medicine clinics","volume":"21","author":"Vas","year":"2010","journal-title":"Int J STD AIDS"},{"key":"2021081616420154800_CIT0027","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1001\/jama.1993.03510170061031","article-title":"Long-term eradication of Chlamydia trachomatis genital infection after antimicrobial therapy: evidence against persistent infection","volume":"270","author":"Workowski","year":"1993","journal-title":"JAMA"},{"key":"2021081616420154800_CIT0028","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1136\/sextrans-2013-051051","article-title":"Lymphogranuloma venereum diagnoses among men who have sex with men in the U.K.: interpreting a cross-sectional study using an epidemic phase-specific framework","volume":"89","author":"Hughes","year":"2013","journal-title":"Sex Transm Infect"},{"key":"2021081616420154800_CIT0029","doi-asserted-by":"crossref","first-page":"20057","DOI":"10.2807\/ese.17.02.20057-en","article-title":"Lymphogranuloma venereum: a hidden emerging problem, Barcelona, 2011","volume":"17","author":"Vargas-Leguas","year":"2012","journal-title":"Euro Surveill"},{"key":"2021081616420154800_CIT0030","article-title":"European Centre for Disease Prevention and Control. Lymphogranuloma venereum","volume-title":"ECDC. Annual epidemiological report for 2017","author":"European Centre for Disease Prevention and Control (ECDC)","year":"2019"},{"key":"2021081616420154800_CIT0031","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/QCO.0000000000000519","article-title":"Lymphoganuloma venereum in the Western world, 15 years after its re-emergence: new perspectives and research priorities","volume":"32","author":"de Vries","year":"2019","journal-title":"Curr Opin Infect Dis"},{"key":"2021081616420154800_CIT0032","doi-asserted-by":"crossref","first-page":"e53","DOI":"10.1086\/597011","article-title":"Delayed microbial cure of Lymphogranuloma venereum proctitis with doxycycline treatment","volume":"48","author":"de Vries","year":"2009","journal-title":"Clin Infect Dis"},{"key":"2021081616420154800_CIT0033","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/imj.13624","article-title":"The efficacy of azithromycin and doxycycline treatment for rectal chlamydial infection: a retrospective cohort study in South Australia","volume":"48","author":"Li","year":"2018","journal-title":"Intern Med J"},{"key":"2021081616420154800_CIT0034","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1136\/sextrans-2015-052297","article-title":"What is the most appropriate treatment for rectal Chlamydia trachomatis infection?","volume":"92","author":"Hathorn","year":"2016","journal-title":"Sex Transm Infect"},{"key":"2021081616420154800_CIT0035","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1093\/jac\/dku574","article-title":"The efficacy of azithromycin and doxycycline for the treatment of rectal Chlamydia infection: a systematic review and meta-analysis","volume":"70","author":"Kong","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"2021081616420154800_CIT0036","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1136\/sextrans-2017-053384","article-title":"Prevalence of Mycoplasma genitalium in different population groups: systematic review andmeta-analysis","volume":"94","author":"Baumann","year":"2018","journal-title":"Sex Transm Infect"},{"key":"2021081616420154800_CIT0037","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1093\/cid\/ciy477","article-title":"Outcomes of resistance-guided sequential treatment of Mycoplasma genitalium infections: a prospective evaluation","volume":"68","author":"Read","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2021081616420154800_CIT0038","doi-asserted-by":"crossref","first-page":"e235","DOI":"10.1016\/S1473-3099(17)30310-9","article-title":"Sexually transmitted infections: challenges ahead","volume":"17","author":"Unemo","year":"2017","journal-title":"Lancet Infect Dis"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/advance-article-pdf\/doi\/10.1093\/cid\/ciab044\/38390693\/ciab044.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/73\/4\/614\/39764016\/ciab044.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/73\/4\/614\/39764016\/ciab044.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,16]],"date-time":"2021-08-16T17:14:32Z","timestamp":1629134072000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/73\/4\/614\/6104234"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,19]]},"references-count":38,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2021,1,19]]},"published-print":{"date-parts":[[2021,8,16]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciab044","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,8,15]]},"published":{"date-parts":[[2021,1,19]]}}}